Common drugs in acute ischemic stroke and their influence on outcome: An observational study in 1013 stroke patients

Clinical Neuropharmacology

Volumn 31, Issue 2, 2008, Pages 74-79

  Aerden, Leo ^a   Van Raak, Elizabeth ^b   Boreas, Anita ^b   Kessels, Alfons ^b   Lodder, Jan ^b  

^a Reinier de Graaf Gasthuis ^*  (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Common drugs; Medication; Neuroprotection; Prognosis; Stroke

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NEUROPROTECTIVE AGENT; STEROID; VASODILATOR AGENT; XANTHINE DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROPROTECTION; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; RISK FACTOR; SEX; STROKE; STROKE PATIENT; THROMBOSIS;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBSERVATION; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME;

EID: 41749083544     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31811ec142     Document Type: Article

References (18)

1. Massing MW, Rywik SL, Jasinski B, et al. Opposing national stroke mortality trends in Poland and for African Americans and whites in the United States, 1968 to 1994. Stroke 1998;29:1366-1372.
2. Vademecum Gezondheidsstatistiek Nederland, 2003:173. Available at: http//www.CBS.nl.
3. Goldstein LB. Influence of common drugs and related factors on stroke outcome. Curr Opin Neurol 1997;10:52-57.
4. de Jong G, van Raak L, Kessels F, et al. Stroke subtype and mortality. A follow-up study in 998 patients with a first cerebral infarct. J Clin Epidemiol 2003;56:262-268.
5. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526.
6. Lodder J, Bamford J, Kappelle J, et al. What causes false clinical prediction of small deep infarcts? Stroke 1994;25:86-91.
7. Aerden L, Luijckx GJ, Ricci S, et al. Validation of the Oxfordshire Community Stroke Project syndrome diagnosis derived from a standard symptom list in acute stroke. J Neurol Sci 2004;220:55-58.
8. Pahor M, Psaty BM, Alderman MH, et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet 2000;356:1949-1954.
9. Horn J, Limburg M. Calcium antagonists for ischemic stroke: a systematic review. Stroke 2001;32:570-576.
10. Siesjo BK, Zhao Q, Pahlmark K, et al. Glutamate, calcium, and free radicals as mediators of ischemic brain damage. Ann Thorac Surg 1995;59:1316-1320.
11. Hornig CR, Bauer T, Simon C, et al. Hemorrhagic transformation in cardioembolic cerebral infarction. Stroke 1993;24:465-468.
12. Weiss DJ, Evanson OA, Geor RJ. The effects of furosemide and pentoxifylline on the flow properties of equine erythrocytes: in vitro studies. Vet Res Commun 1994;18:373-381.
13. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.
14. Lodder J, Heuts-van Raak L, Kessels F. GABA-ergic stimulation by benzodiazepines at stroke onset may ameliorate functional outcome in cardioembolic stroke patients. Cerebrovasc Dis 1996;6:118.
15. Aerden LA, Kessels FA, Rutten BP, et al. Diazepam reduces brain lesion size in a photothrombotic model of focal ischemia in rats. Neurosci Lett 2004;367:76-78.
16. Fassbinder K, Fatar M, Ragoschke A, et al. Subacute but not acute generation of nitric oxide in focal cerebral ischemia. Stroke 2000;31:2208-2211.
17. Lodder J, van Raak L, Hilton A, et al. EGASIS Study Group. Diazepam to improve acute stroke outcome: results of the early GABA-ergic activation study in stroke trial. A randomized double-blind placebo-controlled trial. Cerebrovasc Dis 2006;21:120-127.
18. Heuts-van Raak L. Seizure risk and peri-stroke medication use. In: Seizures Following a First Cerebral Infarct: Risk Factors and Prognosis [dissertation]. Maastricht, Netherlands: University of Maastricht; 1996:chapter 6. ISBN 90-9009220-X.